HUP9800649A2 - Benzil-oxi-csoporttal helyettesített, kondenzált N-heterociklusos vegyületek, eljárás előállításukra és alkalmazásuk bradikinin receptorantagonistaként - Google Patents
Benzil-oxi-csoporttal helyettesített, kondenzált N-heterociklusos vegyületek, eljárás előállításukra és alkalmazásuk bradikinin receptorantagonistakéntInfo
- Publication number
- HUP9800649A2 HUP9800649A2 HU9800649A HUP9800649A HUP9800649A2 HU P9800649 A2 HUP9800649 A2 HU P9800649A2 HU 9800649 A HU9800649 A HU 9800649A HU P9800649 A HUP9800649 A HU P9800649A HU P9800649 A2 HUP9800649 A2 HU P9800649A2
- Authority
- HU
- Hungary
- Prior art keywords
- bradiquinin
- condesed
- benzyloxy
- antagonists
- receptor
- Prior art date
Links
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000019425 cirrhosis of liver Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A találmány tárgya az új, (I) általánős képletű vegyületek, ahől Djelentése (II) vagy (III) általánős képletű gyök, X1 jelentése N vagyC-R6, X2 jelentése N vagy C-R7, X3 jelentése N vagy C-R8, B jelentése(VIII) általánős képletű csőpőrt, R1, R2 jelentése, amelyek lehetnekazőnősak vagy különbözők: 1. hidrőgénatőm, 2. halőgénatőm, 3. (C1-C3)-alkilcsőpőrt. A találmány tárgya tővábbá ezeknek a vegyületeknek azelőállítása, valamint alkalmazásűk gyógyszerként májzsűgőr ésAlzheimer-kór kezelésére és megelőzésére. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19712960A DE19712960A1 (de) | 1997-03-27 | 1997-03-27 | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9800649D0 HU9800649D0 (en) | 1998-05-28 |
HUP9800649A2 true HUP9800649A2 (hu) | 1998-12-28 |
HUP9800649A3 HUP9800649A3 (en) | 1999-01-28 |
Family
ID=7824838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9800649A HUP9800649A3 (en) | 1997-03-27 | 1998-03-25 | Condesed n-heterocyclic compounds substituted with benzyloxy-group, process for producing them, and their use as bradiquinin-receptor-antagonists |
Country Status (16)
Country | Link |
---|---|
US (1) | US6211196B1 (hu) |
EP (1) | EP0867432B1 (hu) |
JP (1) | JPH10279563A (hu) |
KR (1) | KR19980080757A (hu) |
CN (1) | CN1194978A (hu) |
AT (1) | ATE268759T1 (hu) |
AU (1) | AU5965298A (hu) |
BR (1) | BR9801132A (hu) |
CA (1) | CA2232499A1 (hu) |
CZ (1) | CZ91498A3 (hu) |
DE (2) | DE19712960A1 (hu) |
ES (1) | ES2223090T3 (hu) |
HU (1) | HUP9800649A3 (hu) |
NO (1) | NO981383L (hu) |
PL (1) | PL325597A1 (hu) |
TR (1) | TR199800543A2 (hu) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10134721A1 (de) * | 2001-07-17 | 2003-02-06 | Bayer Ag | Tetrahydrochinoxaline |
US6492517B1 (en) * | 2001-07-19 | 2002-12-10 | Air Products And Chemicals, Inc. | Method for preparing halomethyl heterocyclic compounds |
WO2003087090A2 (en) * | 2002-04-10 | 2003-10-23 | Ortho-Mcneil Pharmaceutical,Inc. | Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
WO2003093245A1 (en) * | 2002-05-03 | 2003-11-13 | Elan Pharmaceuticals, Inc. | Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
ITMI20021247A1 (it) * | 2002-06-07 | 2003-12-09 | Menarini Ricerche Spa | Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche |
WO2006094034A1 (en) | 2005-03-01 | 2006-09-08 | Wyeth | Cinnoline compounds and their use as liver x receptor modilators |
TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽b2受體調節劑 |
CA2944103A1 (en) | 2014-05-07 | 2015-11-12 | Evotec International Gmbh | Sulfoximine substituted quinazolines for pharmaceutical compositions |
CA3082948A1 (en) | 2017-11-24 | 2019-05-31 | Pharvaris Netherlands B.V. | Novel bradykinin b2 receptor antagonists |
UY38706A (es) | 2019-05-23 | 2020-12-31 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
KR20240039185A (ko) | 2021-08-05 | 2024-03-26 | 파르바리스 게엠베하 | 브래디키닌 b2-수용체 길항제의 경구 투여용 지질 기반 조성물 |
WO2023180575A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Solid composition comprising solubilised bradykinin b2-receptor antagonists |
TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽b2受體拮抗劑之固態延長釋放組成物 |
WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202336A (en) * | 1986-09-24 | 1993-04-13 | Bayer Aktiengesellschaft | Antiflammatory quinolin methoxy phenylsulphonamides |
AU680870B2 (en) * | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
KR970707098A (ko) * | 1994-10-27 | 1997-12-01 | 후지야마 아키라 | 브라디키닌 길항제로서 피리도피리미돈, 퀴놀린 및 융합된 N-헤테로사이클(Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists) |
FR2735128B1 (fr) * | 1995-06-07 | 1997-07-25 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique. |
FR2737892B1 (fr) * | 1995-08-17 | 1997-10-24 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique |
GB9519077D0 (en) * | 1995-09-18 | 1995-11-15 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
DE19610784A1 (de) * | 1996-03-19 | 1997-09-25 | Hoechst Ag | Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung |
EP0808627A2 (de) | 1996-05-22 | 1997-11-26 | Hoechst Aktiengesellschaft | Verwendung nicht-peptidischer Bradykinin-Antagonisten zur Behandlung und Prävention von chronisch-fibrogenetischen Lebererkrankungen, akuten Lebererkrankungen und den damit verbundenen Komplikationen |
SI0835659T1 (en) * | 1996-10-14 | 2005-06-30 | Aventis Pharma Deutschland Gmbh | Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease |
-
1997
- 1997-03-27 DE DE19712960A patent/DE19712960A1/de not_active Withdrawn
-
1998
- 1998-03-18 CA CA002232499A patent/CA2232499A1/en not_active Abandoned
- 1998-03-23 ES ES98105200T patent/ES2223090T3/es not_active Expired - Lifetime
- 1998-03-23 AT AT98105200T patent/ATE268759T1/de not_active IP Right Cessation
- 1998-03-23 DE DE59811526T patent/DE59811526D1/de not_active Expired - Lifetime
- 1998-03-23 EP EP98105200A patent/EP0867432B1/de not_active Expired - Lifetime
- 1998-03-25 HU HU9800649A patent/HUP9800649A3/hu unknown
- 1998-03-25 TR TR1998/00543A patent/TR199800543A2/xx unknown
- 1998-03-25 CZ CZ98914A patent/CZ91498A3/cs unknown
- 1998-03-26 JP JP10079423A patent/JPH10279563A/ja not_active Ceased
- 1998-03-26 US US09/048,305 patent/US6211196B1/en not_active Expired - Fee Related
- 1998-03-26 CN CN98105890A patent/CN1194978A/zh active Pending
- 1998-03-26 NO NO981383A patent/NO981383L/no unknown
- 1998-03-26 AU AU59652/98A patent/AU5965298A/en not_active Abandoned
- 1998-03-26 BR BR9801132A patent/BR9801132A/pt not_active Application Discontinuation
- 1998-03-27 PL PL98325597A patent/PL325597A1/xx unknown
- 1998-03-27 KR KR1019980010670A patent/KR19980080757A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR9801132A (pt) | 2000-03-21 |
TR199800543A2 (xx) | 1998-10-21 |
KR19980080757A (ko) | 1998-11-25 |
AU5965298A (en) | 1998-10-01 |
ES2223090T3 (es) | 2005-02-16 |
JPH10279563A (ja) | 1998-10-20 |
NO981383D0 (no) | 1998-03-26 |
MX9802372A (es) | 1998-09-30 |
HU9800649D0 (en) | 1998-05-28 |
EP0867432A3 (de) | 1998-10-14 |
US6211196B1 (en) | 2001-04-03 |
EP0867432B1 (de) | 2004-06-09 |
PL325597A1 (en) | 1998-09-28 |
CN1194978A (zh) | 1998-10-07 |
DE19712960A1 (de) | 1998-10-01 |
HUP9800649A3 (en) | 1999-01-28 |
CA2232499A1 (en) | 1998-09-27 |
CZ91498A3 (cs) | 1998-10-14 |
ATE268759T1 (de) | 2004-06-15 |
EP0867432A2 (de) | 1998-09-30 |
NO981383L (no) | 1998-09-28 |
DE59811526D1 (de) | 2004-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9800649A2 (hu) | Benzil-oxi-csoporttal helyettesített, kondenzált N-heterociklusos vegyületek, eljárás előállításukra és alkalmazásuk bradikinin receptorantagonistaként | |
HUP0402507A2 (hu) | N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
HUP0004419A2 (hu) | Aril-oxi-alkil-dialkil-amin-származékok és előállításuk | |
FI913478A0 (fi) | Diazinderivat. | |
CY1106297T1 (el) | Παραγωγα πυραζολης χρησιμα ως αναστολεις κινασης πρωτεϊνης | |
NO20025955D0 (no) | 1,2-dihydropyridinforbindelser, fremgangsmåte for fremstilling av de sammeog anvendelse derav | |
NO910712D0 (no) | Fremgangsmaate ved fremstilling av oksetanoner. | |
PT863875E (pt) | Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal | |
TW200716520A (en) | 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands | |
SE0102299D0 (sv) | Compounds | |
SE0102300D0 (sv) | Compounds | |
ES2163638T3 (es) | Nuevas n-(1-alquil-5-fenil-2,3,4,5-tetrahidro-1h-benzo(b)(1,5)diacepin-3-il)acetamidas. | |
HUP9700884A2 (hu) | Tienil-etilamino-halogénfenil-acetamid intermedierek és eljárás előállításukra | |
ES2193241T3 (es) | Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
TW200619212A (en) | Morpholine derivatives | |
DE60133817D1 (de) | Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung | |
ATE12503T1 (de) | 1-beta-d-arabinofuranosyl-(e)-5-(2halogensubstituiertes vinyl) uracil-5-phosphate; ihre herstellung und verwendung. | |
DE60015508T2 (de) | C-16 ungesätigte fp-selektive prostaglandin analoge | |
HU9300533D0 (en) | Tropolone derivatives, method for producing them medical preparatives for preventing and treating ischemic diseases containing said compounds and method for preparing them | |
CY1105550T1 (el) | Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους | |
ES2194102T3 (es) | Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
DE59910677D1 (de) | Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen | |
YU3099A (sh) | Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena | |
PL338348A1 (en) | Thiazolobenzenoheterocyclic compounds, their production and drugs containing them | |
DE69725167D1 (de) | N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung |